Orthocell Ltd (ASX:OCC, OTC:ORHHF) has reported encouraging early clinical results for its Remplir™ nerve repair technology in prostate cancer surgery, with 80% of patients demonstrating positive urinary continence outcomes and 75% of eligible patients showing a return of erectile function. The findings from an initial five-patient case series involving advanced prostate cancer patients support...
CHICAGO--(BUSINESS WIRE)--OCC today announced it will provide CCP and settlement services for IEX Options LLC, a new options exchange from Investors' Exchange LLC.
Orthocell Ltd (ASX:OCC, OTC:ORHHF) has recorded the first commercial sales of its Remplir™ nerve repair product in Thailand, extending the regenerative medicine company's Asian footprint and opening another revenue-generating market for the product. The first sales follow Thai FDA approval and the appointment of MediTime as Orthocell's exclusive in-country distributor, giving the company an est...
CHICAGO--(BUSINESS WIRE)--OCC today announced it will provide central counterparty clearing and settlement services for MX2 Options, a new options exchange from MEMX Group.
Net Sales Increased 22.0% and Gross Profit Increased 43.9% in the Third Quarter of Fiscal 2026 Compared to Same Period in Prior Year ROANOKE, Va., Sept. 9, 2026 /PRNewswire/ -- Optical Cable Corporation (Nasdaq GM: OCC) ("OCC®" or the "Company") today announced financial results for its third quarter of fiscal year 2026 ended July 31, 2026.
The Federal Deposit Insurance Corporation has prevailed in a case stemming from Silicon Valley Bank's collapse. As Reuters reported Monday (Aug. 31), a federal judge has ruled that the former parent company of the bank (SVB) cannot pursue a $1.71 billion claim against the regulator (FDIC).
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.